adakveo
novartis europharm limited - crizanlizumab - anemija, srčna celica - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.
locametz
novartis europharm limited - gozetotide - radionuklidno slikanje - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
azarga
novartis europharm limited - brinzolamide, timolol maleate - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje intraokularnega tlaka (iop) pri odraslih bolnikih z glavkomom odprtega zakotja ali očesno hipertenzijo, pri kateri monoterapija ne zagotavlja zadostnega znižanja iop.
azopt
novartis europharm limited - brinzolamid - glaucoma, open-angle; ocular hypertension - oftalmologi - azopt je označen za znižanje zvišanega očesnega tlaka v:očesni hipertenzija;odprtega zakotja glaucomaas monotherapy pri odraslih bolnikih, neodzivni na beta-blokatorji ali pri odraslih bolnikih, pri katerih beta-blokatorji so kontraindicirana, ali kot adjunctive zdravljenje z beta blokatorji ali podobne snovi, prostaglandinov.
izba
novartis europharm limited - travoprost - ocular hypertension; glaucoma, open-angle - ophthalmologicals, antiglaucoma preparations and miotics - zmanjšanje zvišanega očesnega tlaka pri odraslih bolnikih z očesno hipertenzijo ali glavkomom odprtega zakotja (glejte poglavje 5. znižanje zvišanega očesnega tlaka pri pediatričnih bolnikih, starih od 3 let < 18 let, s očesni hipertenzijo ali glavkom pediatričnih.
simbrinza
novartis europharm limited - brinzolamide, brimonidine tartrat - ocular hypertension; glaucoma, open-angle - oftalmologi - zmanjšanje zvišanega očesnega tlaka (iop) pri odraslih bolnikih z glavkomom odprtega zakotja ali očesno hipertenzijo, pri kateri monoterapija ne zagotavlja zadostnega znižanja iop.
zelnorm
novartis europharm limited - tegaserod - sindrom razdražljivega črevesa - zdravila za funkcionalne prebavne motnje - zelnorm je primerna za večkratno simptomatsko kratkotrajno zdravljenje žensk z sindrom razdražljivega Črevesja (ibs), katerih prevladujoča črevesja navada je, zaprtje, povezane z trebušne bolečine/nelagodje ali napihnjenost (glej poglavje 4.
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatic neoplazem, kastracija-odporne - terapevtski radiofarmacevtiki - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastična sredstva - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
reasanz
novartis europharm ltd - serelaxin - odpoved srca - drugi vasodilators ki se uporabljajo v srčni bolezni - zdravljenje akutnega srčnega popuščanja.